Top COVID-19 vaccines and drugs by 1st HY sales worldwide 2021 | Statista

In 2021, COVID-19 vaccine Comirnaty generated nearly 20 billion U.S. dollars in worldwide sales in the first half of the year. It was not only the bestselling COVID-19-related product in this time period. It was also on track to become the bestselling pharmaceutical product of all time. This statistic illustrates the bestselling COVID-19 vaccines and drugs worldwide in 1st HY 2021.

Bestselling COVID-19 vaccines and drugs worldwide in 1st HY 2021 (in billion U.S. dollars)

Product name (specification), manufacturer	Sales in billion U.S. dollars
BNT162b2 (sold as Comirnaty in EU and Switzerland), BioNTech/Pfizer	19.93
mRNA-1273 (sold as Spikevax in Europe), Moderna	5.93
REGEN-COV/Ronapreve (casirivimab and imdevimab), Regeneron and Roche	4.16
Veklury (remdesivir), Gilead Sciences	2.29
Actemra/RoActemra, Roche and Genentech	1.64
COVID-19 Vaccine AstraZeneca (AZD1222; sold as Vaxzevria in Europe)	1.14
Bamlanivimab and etesevimab, Eli Lilly	0.96
Olumiant, Eli Lilly	0.4
Single-Shot COVID-19 Vaccine, Johnson & Johnson	0.26
Regkirona, Celltrion Healthcare	0.04
Sotrovimab, GSK and Vir Biotechnology	0.02

Loading statistic...

Download

Source

Show detailed source information?

Register for free

Already a member?

Source

Use Ask Statista Research Service

Release date

September 2021

More information

Region

Worldwide

Survey time period

1st HY 2021

Citation formats

Other statistics on the topic
Pfizer

Coronavirus (COVID-19) deaths worldwide per one million population as of July 13, 2022, by country

State of Health

COVID-19 cases and deaths per million in 210 countries as of July 13, 2022

Rate of COVID-19 vaccine doses administered worldwide as of March 20, 2023, by select country, territory, or region (per 100 people)

State of Health

COVID-19 vaccine dose rate worldwide by select country or territory March 20, 2023

Number of COVID-19 vaccine doses administered worldwide as of March 20, 2023, by country

State of Health

COVID-19 vaccine doses administered worldwide as of March 20, 2023, by country

Leading companies by number of COVID-19 drugs and vaccines in development as of June 3, 2022

Pharmaceutical Products & Market

Top companies by COVID-19 treatment vaccines in development June 2022

Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Starter Account

The ideal entry-level account for individual users

Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references

$149 USD / Month *

Professional Account

Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Coronavirus (COVID-19): vaccines and vaccination campaign "

The most important statistics

The most important statistics

The most important statistics

The most important statistics

The most important statistics

The most important statistics

Other statistics that may interest you Coronavirus (COVID-19): vaccines and vaccination campaign

Pandemic situation

5

Search for vaccines

7

Leading products and companies

7

Vaccination campaign

5

Distribution inequality

5

Vaccination approval and willingness

8

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Coronavirus disease (COVID-19) pandemic

Coronavirus COVID-19 in China

COVID-19: impact on the tourism industry worldwide

Coronavirus (COVID-19) in the Asia-Pacific region

Coronavirus (COVID-19) in Italy

Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year

Learn more about how Statista can support your business.